Opus Genetics IRD Insider Ownership

NASDAQ IRD

$4.18 -0.02 (-0.60%)

As of: Nov 10, 2026 · 2:45 PM EST

Insider Holdings by Owner

12.94Mn Shares

Fighting Blindness Retinal Degeneration Fund Foundation3.24Mn25.0%

Cam Gallagher2.80Mn21.6%

George Magrath2.01Mn15.5%

Benjamin R Yerxa670.92K5.2%

Robert E. Gagnon542.38K4.2%

Other insiders (14)3.68Mn28.4%

Insider Ownership Statistics

as of 30 Sep, 2026

Insider Ownership

13.00%

▲+0.511% pp QoQ

Shares Held by Insiders

12.41Mn

filed for Sep 2026

▲+4.09% QoQ

Shares Outstanding

95.48Mn

95,483,280 shares

Direct Holdings

12.33Mn

Indirect: 83.00K

Net Open-Market Trades

-613.33K

net sold · -$2.97Mn in Sep 2026

Insiders Holding Shares

with Form 4 holdings on file

Shares Owned by Insiders

Shares held % of outstanding

Latest —

Average ownership —

Peak ownership —

Open-Market Insider Trades

Bought Sold

Latest quarter —

Net over range —

Net-buying quarters —

Insider Ownership Summary

Updated Nov 5, 2026

In the last 12 months, insiders at Opus Genetics made open-market purchases of $323,693 (164K shares) and open-market sales of $19.57 million (6.45Mn shares).

Behind Opus Genetics' open-market trades in the past 12 months were one insider buying and 7 insiders selling.
Among Opus Genetics insiders, Cam Gallagher (Director) led open-market buying over the past 12 months with $323,693 of purchases (164K shares); the latest was on December 29, 2025.
Conversely, Fighting Blindness Retinal Degeneration Fund Foundation (Director) was IRD's largest open-market seller in the past 12 months, with $18.75 million of sales (6.26Mn shares); the latest was on September 30, 2026.
The latest open-market trade in IRD stock by an insider was a sale of 33.19K shares for $117,365 by Benjamin R. Yerxa (President) on October 23, 2026.
Away from the open market, IRD insiders received 1.46Mn shares in stock awards, acquired 1.18Mn shares through option exercises and conversions and gave up 88.19K shares to cover taxes or exercise prices over the last 12 months.
Business Quant data shows Opus Genetics insiders holding 12.35Mn shares in total in their latest Form 4 filings, up 3.57% from 11.92Mn shares at the end of Q2 2026 and down 20.13% from 15.46Mn shares at the end of Q3 2025.
Of the 12.35Mn shares held by Opus Genetics insiders, 12.27Mn shares (99.33%) are held directly and 83K shares (0.67%) indirectly, through trusts, partnerships, family members and other entities.
The insider holdings in Opus Genetics belong to 16 insiders who have reported on Form 4 within the past two years.
Opus Genetics' top three insider holders by shares held are Fighting Blindness Retinal Degeneration Fund Foundation (Director, 3.24Mn shares), Cam Gallagher (Director, 2.88Mn shares) and George Magrath (Chief Executive Officer, 2.04Mn shares).
Fighting Blindness Retinal Degeneration Fund Foundation holds 26.21% of the combined insider position in Opus Genetics.
Institutions held 60.23% of Opus Genetics' outstanding shares in their Q2 2026 13F filings, insiders about 12.93% based on their latest Form 4 filings, and other investors, including the public, the remaining 26.84%.
Over the past 12 months, 14 insiders reported transactions in Opus Genetics stock in 47 Form 4 filings.
The insider data for IRD reflects Form 4 filings through October 27, 2026.

Form 4 Holdings

Insiders Holding IRD

Insiders 19

Shares held 12.94Mn

Of outstanding 13.55%

#	Insider	Position	Direct	Total	Share of Insiders	Last Filed
1	Fighting Blindness Retinal Degeneration Fund Foundation	Director, Other	3,236,171	3,236,171	25.0%	02 Oct, 2026
2	Cam Gallagher	Director	2,800,111	2,800,111	21.6%	08 Sep, 2026
3	George Magrath	Chief Executive Officer	2,010,636	2,010,636	15.5%	05 Nov, 2026
4	Benjamin R Yerxa	President	670,917	670,917	5.2%	27 Oct, 2026
5	Robert E. Gagnon	Chief Financial Officer	542,375	542,375	4.2%	27 Oct, 2026
6	Ashwath Jayagopal	Chief Scientific Dev. Ofc.	509,233	509,233	3.9%	27 Apr, 2026
7	Mina Sooch	President And Ceo	430,501	430,501	3.3%	12 Jan, 2023
8	Richard J Rodgers	Interim Ceo And President	343,022	343,022	2.7%	22 Apr, 2026
9	Sean Ainsworth	Director	321,692	321,692	2.5%	22 Apr, 2026
10	James S J Manuso	Director	317,318	317,318	2.5%	22 Apr, 2026
11	Joseph K Schachle	Chief Operating Officer	286,673	286,673	2.2%	27 Oct, 2026
12	Jean Bennett	Director	259,019	259,019	2.0%	22 Apr, 2026
13	Susan Benton	Director	243,894	243,894	1.9%	22 Apr, 2026
14	Nirav S. Jhaveri	Chief Financial Officer	194,293	194,293	1.5%	17 Mar, 2025
15	Rabourn Amy Zaremba	Head Of Fin. Quality Assurance	188,671	188,671	1.5%	27 Apr, 2026
16	Bernhard Hoffmann	Svp Of Corp. Dev.	185,446	185,446	1.4%	17 Mar, 2025
17	Jay Pepose	Director	180,458	180,458	1.4%	13 Jun, 2024
18	Adrienne L Graves	Director	127,514	127,514	1.0%	22 Apr, 2026
19	Ronil A. Patel	Chief Business Officer	90,714	90,714	0.7%	12 Jan, 2024

Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.

Form 4 Filings

486 Insider Transactions

Source SEC Form 4

Latest quarter Sep 2026

Date	Insider	Position	Transaction	Shares	Price	Value	Shares Held After	Ownership
03 Nov, 2026	George Magrath	Chief Executive Officer	Disposed S	28,258	$3.90	$110.18K	2,010,636	Direct
23 Oct, 2026	George Magrath	Chief Executive Officer	Disposed S	9,591	$3.59	$34.38K	2,038,894	Direct
23 Oct, 2026	Joseph K Schachle	Chief Operating Officer	Disposed S	4,767	$3.57	$16.99K	286,673	Direct
23 Oct, 2026	Robert E. Gagnon	Chief Financial Officer	Disposed S	14,000	$3.55	$49.65K	542,375	Direct
23 Oct, 2026	Benjamin R Yerxa	President	Disposed S	7,669	$3.55	$27.24K	696,437	Direct
23 Oct, 2026	Benjamin R Yerxa	President	Disposed S	25,520	$3.53	$90.13K	670,917	Direct
30 Sep, 2026	Fighting Blindness Retinal Degeneration Fund Foundation	Director, Other	Disposed S	556,000	$4.96	$2.76Mn	3,236,171	Direct
09 Sep, 2026	George Magrath	Chief Executive Officer	Acquired M	392,157	$1.15	$450.98K	2,124,026	Direct
09 Sep, 2026	George Magrath	Chief Executive Officer	Disposed F	75,541	$5.97	$450.98K	2,048,485	Direct
09 Sep, 2026	George Magrath	Chief Executive Officer	Disposed M	392,157	$0.00	$0	0	Direct
08 Sep, 2026	Cam Gallagher	Director	Acquired M	784,314	$1.15	$901.96K	2,800,111	Direct
03 Sep, 2026	Robert E. Gagnon	Chief Financial Officer	Disposed S	28,000	$4.54	$127.21K	556,375	Direct
08 Sep, 2026	Cam Gallagher	Director	Disposed M	784,314	$0.00	$0	0	Direct
23 Jul, 2026	Joseph K Schachle	Chief Operating Officer	Disposed S	4,644	$2.94	$13.65K	291,440	Direct
23 Jul, 2026	Robert E. Gagnon	Chief Financial Officer	Disposed S	7,783	$2.95	$22.94K	584,375	Direct
23 Jul, 2026	Benjamin R Yerxa	President	Disposed S	7,429	$2.97	$22.06K	704,106	Direct
23 Jul, 2026	George Magrath	Chief Executive Officer	Disposed S	9,475	$2.95	$27.93K	1,731,869	Direct
18 May, 2026	Fighting Blindness Retinal Degeneration Fund Foundation	Director, Other	Disposed S	1,700,000	$4.35	$7.39Mn	3,792,171	Direct
23 Apr, 2026	Rabourn Amy Zaremba	Head Of Fin. Quality Assurance	Disposed S	1,641	$5.20	$8.54K	188,671	Direct
23 Apr, 2026	Joseph K Schachle	Chief Operating Officer	Disposed S	4,697	$5.22	$24.52K	296,084	Direct

Showing 1 to 20 of 486 transactions